Parasitology is a multidisciplinary field that focuses on the study of parasites, their hosts, and their interactions. While other fields may examine organisms or environments, parasitology centers on understanding the parasites themselves. It draws from various disciplines such as cell biology, bioinformatics, biochemistry, molecular biology, immunology, genetics, evolution, and ecology to investigate the biology, behavior, life cycles, and evolutionary relationships of parasites. This integrated approach allows for a comprehensive understanding of the complex dynamics between parasites and their hosts.
According to Data Bridge Market Research, the Parasitology Identification Market valued at USD 4,092.15 million in 2022, will reach USD 6,522.27 million by 2030, growing at a CAGR of 6% during the forecast period of 2023 to 2030.
" Increasing prevalence of parasitic infections surge market demand"
The increasing prevalence of parasitic infections worldwide is a major driver for the demand for accurate and efficient diagnostic tools in parasitology identification. With the growing incidence of these infections, there is a greater need for timely and accurate detection to facilitate appropriate treatment interventions. Improved diagnostic tools play a crucial role in identifying the specific parasites responsible for infections, enabling healthcare professionals to implement targeted treatment strategies and prevent further spread of parasitic diseases. This increased focus on early detection and treatment drives the demand for advanced diagnostic tools in the parasitology identification market.
What restraints the growth of the parasitology identification market?
" High cost of advanced diagnostic tools can impede the market growth”
The high cost of advanced diagnostic tools for parasitology identification poses a significant restraint on market growth. In resource-limited settings, healthcare facilities often face budget constraints and prioritize essential healthcare needs. The expensive nature of molecular assays and imaging systems can limit their adoption, hindering the accurate and efficient diagnosis of parasitic infections.
Segmentation: Global Parasitology Identification Market
The parasitology identification market is segmented on the basis of product, method, pathogen type, sample, stool concentration and preparation, and end user.
- On the basis of products, the parasitology identification market is segmented into consumables and accessories, devices.
- On the basis of methods, the parasitology identification market is segmented into microscopic identification, fecal identification, immunological techniques, morphological identification, molecular techniques, rapid diagnostic tests (rdts), maldi-tof ms, others.
- On the basis of pathogen type, the parasitology identification market is segmented into protozoan, helminths, arthropodes, tapeworm, and ectoparast.
- On the basis of sample, the parasitology identification market is segmented into feces, blood, urine, cerebrospinal fluid (csf), serum and plasma, other.
- On the basiso of stool concentration and preparation, the parasitology identification market is segmented into concentration technique, un-concentration technique.
- On the basis of end user, the parasitology identification market is segmented into diagnostic centers, hospitals, clinics, ambulatory surgical centres, and others.
Regional Insights: North America dominates the Global Parasitology Identification Market
North America's dominance in the parasitology identification market can be attributed to its large consumer market and high gross domestic product. The region's strong economic position and high healthcare expenditure create a conducive environment for market growth. Within North America, the United States holds a prominent position, driven by factors such as rising healthcare costs, increased investment in parasitology-related research and development, and advancements in diagnostic tools. These factors contribute to the growth of the parasitology identification market in the United States and reinforce North America's overall dominance in the industry.
The Asia-Pacific region is expected to experience significant growth in the parasitology identification market due to various factors. The upgradation of medical infrastructure in the region, driven by the increasing focus on healthcare advancements, is contributing to the demand for advanced diagnostic tools. Additionally, government initiatives and regulatory bodies' efforts to control parasitic infections are further propelling market growth. Among the countries in the region, China stands out as a dominant player due to its rising product usage, advancements in parasitology identification, and strong healthcare system, positioning it as a key market within the Asia-Pacific region.
To know more about the study, visit, https://www.databridgemarketresearch.com/reports/global-parasitology-identification-market
Recent Developments in Global Parasitology Identification Market
- In 2020, Using its most recent rapid diagnostic malaria kit and the industry standard test, Abbott conducted a malaria study in the Mpigi district. Abbott's rapid diagnostic test produced some ground-breaking findings, with a positivity rate that was double that of the conventional test. The company's brand value in the marketplace has increased as a result.
- In 2020, The BD FACSDUET automated flow cytometer system has received approval. Automation solutions for flow cytometry like the BD FACSDuetTM and BD FACSLyricTM Complete Sample-to-Answer Solution help to increase throughput and provide consistent results that clinicians rely on to guide patient care by increasing accuracy and standardization from instrument to instrument and operator to operator.
The Prominent Key Players Operating in the Global Parasitology Identification Market Include:
- Abbott (U.S.)
- BD (U.S.)
- bioMérieux, Inc.(France)
- Bruker (U.S.)
- Quest Diagnostics (U.S.)
- Akron Biotech (U.S.)
- Thermo Fisher Scientific Inc (U.S.)
- altona Diagnostics GmbH (Germany)
- Biomerica (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Creative Diagnostics (U.S.)
- Luminex Corporation (U.S.)
- Meridian Bioscience, Inc. (U.S.)
- R-Biopharm AG (Germany)
- Shimadzu Corporation (Japan)
- Institut Virion/Serion (Germany)
- VWR International, LLC. (U.S.)
- Hardy Diagnostics (U.S.)
- TECHLAB, Inc. (U.S.)
- Alpha-Tec (U.S.)
- Medical Chemical Corporation (MCC). (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global parasitology identification market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Parasitology Identification Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by dbmr research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.
